[INM] QoQ Quarter Result on 30-Jun-2022 [#Q4]

Stock
[INM] InMed Pharmaceuticals Inc.
Announcement Date
23-Sep-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q4]
Profit Trend
QoQ- -126.41%
YoY- -141.49%
Quarter Report
INM's Result
INM's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 1,034 470 321 515 310 265 0 -
PBT -1,996 -2,098 -3,503 -7,870 -3,476 -4,283 -2,972 -23.32%
Tax 2 3 7 -34 -31 22 79 -91.39%
NP -1,998 -2,101 -3,510 -7,870 -3,476 -4,283 -2,972 -23.27%
Tax Rate - - - - - - - -
Total Cost 3,032 2,571 3,831 8,385 3,785 4,548 2,972 1.34%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -193.24 -447.25 -1,094.24 -1,528.88 -1,122.69 -1,615.60 0.00 -
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.60 -0.91 -4.06 -12.22 -6.14 -7.73 -6.17 -78.88%
EPS Diluted -0.60 -0.91 -4.06 -12.22 -6.14 -7.73 -6.17 -78.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.